Cytokine response in lower extremity ischaemia/reperfusion

Area of Science:

• Vascular Surgery
• Inflammation Biology
• Biomedical Research

Background:

• Acute lower extremity ischemia and reperfusion trigger pro-inflammatory responses.
• Understanding cytokine dynamics is crucial for managing reperfusion injury.
• Interleukin-6 (IL-6) is a key mediator in inflammatory processes.

Purpose of the Study:

• To investigate local and systemic concentrations of pro-inflammatory cytokines.
• To determine the role of cytokines in acute lower extremity ischemia and reperfusion injury.
• To assess the correlation between cytokine levels and markers of organ damage.

Main Methods:

• Studied 19 patients undergoing femoral artery thromboembolectomy.
• Collected blood samples from femoral vein (local) and radial artery (systemic) at baseline and 2, 12, 24 hours post-reperfusion.
• Measured concentrations of IL-2 receptor, IL-6, IL-1 beta, IL-8, creatinine kinase, and lactic dehydrogenase; assessed alveolar-arterial oxygen gradient.

Main Results:

• Significant increases in local and systemic IL-2 receptor and IL-6 concentrations post-reperfusion.
• Significant increase in systemic IL-8 concentration.
• Progressively increasing IL-6 in femoral vein suggests local production, correlating with creatinine kinase and A-a oxygen gradient.

Conclusions:

• Interleukin-6 (IL-6) plays a significant role in acute arterial occlusion and reperfusion injury.
• Local IL-6 production is a key factor in the inflammatory response to ischemia-reperfusion.
• Cytokine profiling provides insights into the mechanisms of reperfusion injury.